Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

NCT01768403 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01768403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01768403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
March 31, 2011
Enrollment
1,236 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, coronary heart disease, diabetes, hypercholesterolemia, hypertension, peripheral arterial disease